PharmaCyte Biotech Inc (PMCB)

[rcstock]

The delay of the release of the TD2 tests has clearly led to the current decline. It has given the naysayers the " CIAB doesn't work " mantra. The impatient longs ha also wavered. We realize why they delayed, to study the minimum dosage for the upcoming clinical trials. In hindsight they should have published some results of the latest test. That's what we expected in late May. Now we will have to wait till probably late July to see any concrete news ( either the TD2 results or the blessing of the CIAB facility. I'm still holding and won't sell a single share, but management needs to give us some REAL results.